Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC1992 Er-38925
Retinoic acid receptor (RAR) subtype α-selective agonist
More description
DCC1991 Er-119884
Selective squalene synthase (SQS) inhibitor
More description
DCC1990 Er Degrader 40
Novel Oral Selective Estrogen Receptor Degrader with Highly Improved Antitumor Effect and Favorable Druggability
More description
DCC1989 Epz033294
Novel SMYD2 inhibitor
More description
DCC1988 Epz032597
Novel selective SMYD2 inhibitor
More description
DCC1986 Epz005687n
Inactive isomer of EPZ005687 and can be used as the negative control for EPZ005687
More description
DCC1985 Eptapirone Fumarate
Potent, selective, high efficacy 5-HT1A receptor agonist
More description
DCC1984 Eps-in-1
Novel inhibitor of extracellular polymeric substances (EPS)
More description
DCC1983 Eprazinone
Mucolytic and bronchospasm relieving agent
More description
DCC1982 Epi-nocardicin G
The precursor of the nocardicins
More description
DCC1981 Epinastine Hydrobromide
Second-generation antihistamine and mast cell stabilizer, being highly selective for the H1 receptor
More description
DCC1980 Epibestatin Hydrochloride
Novel stabilizer of 14-3-3 PPIs, Diastereoepimer of aminopeptidase inhibitor bestatin
More description
DCC1979 Epi-0023
Novel selrctive SETD8 inhibitor without inhibiting G9a, SETD7, RmtA, and PRMT1
More description
DCC1978 Ephb3-in-9
The first potent and specific inhibitor of a single Eph isoform EphB3
More description
DCC1977 Ephb3-in-10
Novel clickable potent and specific inhibitor of EphB3
More description
DCC1976 Ephb1-in-10
Potent and selective covalent inhibitor of receptor tyrosine kinase EphB1
More description
DCC1975 Epha2-agonist-27
Novel agonist of EphA2 receptor tyrosine kinase
More description
DCC1974 Epetraborole R-mandelate
Novel potent and selective leucyl-tRNA synthetase inhibitor
More description
DCC1973 Epc-k1
Vitamin E derivative, suppressing inflammation during hepatic ischemia-reperfusion injury and exerting hepatoprotective effects
More description
DCC1972 Ep-7041
Novel, potent, and selective Factor XIa inhibitor
More description
DCC1971 Ent-verticilide
Unnatural verticilide enantiomer, inhibiting type 2 ryanodine receptor-mediated calcium leak and being antiarrhythmic.
More description
DCC1970 Entpd5-in-2f
Novel inhibitor of Ectonucleoside Triphosphate Diphosphohydrolase 5 (ENTPD5)
More description
DCC1969 Entpd5-in-1a
Novel inhibitor of Ectonucleoside Triphosphate Diphosphohydrolase 5 (ENTPD5)
More description
DCC1967 Ent Naxagolide Hydrochloride
Dopamine D2-receptor agonist for the treatment of extrapyramidal disorders, also being an antiparkinson agent
More description
DCC1966 Enprostil
PGE2 analog, inhibiting gastric acid secretion
More description
DCC1965 Enpp1 Inhibitor 43
Novel potent inhibitor of ecto-nucleotide pyrophosphatase/phosphodiesterases 1 (ENPP1 or NPP1), showing good in vitro potency, stability in SGF/SIF/PBS, selectivity, ADME properties and pharmacokinetic profile and finally potent anti-tumor response in viv
More description
DCC1964 Enmd-2076 Tartrate
Novel oral inhibitor of angiogenic and proliferation kinases, having activity in recurrent, platinum resistant ovarian cancer
More description
DCC1963 Enl-in-7
Novel potent inhibitor of eleven-nineteen leukemia (ENL) protein, selectively targeting the ENL YEATS domain
More description
DCC1962 Eniporide Hydrochloride
Sodium/hydrogen exchange inhibitor
More description
DCC1961 Endosidin8.1
Novel modulator of the PIN1 accumulation, selectively modifying PIN1 basal plasma membrane targeting in Arabidopsis with minimal effects on apical plasma membrane proteins
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X